Keep up with what's happening in the crypto world in real-time.
All Filters (1)
In an announcement on April 29, Tether, the issuer of popular stablecoin USDT, revealed its strategic investment of $200 million into Blackrock Neurotech, a leading neural implant company.
The firm behind the top US dollar-pegged stablecoin by market cap is investing hundreds of millions of dollars in a “brain-computer-interface” (BCI) company. In a new announcement, USDT-issuer Tether says they have invested $200 million in Blackrock Neurotech, making Tether the majority stakeholder in the firm.
Tether's investment in Blackrock Neurotech will fund the launch and commercialization of the company's medical solutions.
Circle's stablecoin has overtaken USDT to become the market leader in transaction volume.
Tether's strategic investment will greatly assist Blackrock Neurotech in achieving its objectives.
Visa Inc. data shows Circle's USD Coin outperformed the bellwether Tether (USDT) in transaction volume so far in 2024. Recent starts show that USDC's market share has grown steadily since early January. The stablecoin saw $456 billion in transactions over the last week, eclipsing Tether's $89 billion.
Senators sent letters to several departments about Russia, Iran, and North Korea possibly using Tether's stablecoin to avoid U.S. sanctions.
Tether makes a big play in the biotech industry, securing the majority stake in Blackrock Neurotech.
Tether, the largest company in the digital asset industry, has announced a strategic investment of $200 million into Blackrock Neurotech, a leading pioneer in Brain-Computer-Interface (BCI) technology. This significant move marks the unveiling of Tether's new venture division, Tether Evo, which CEO Paolo Ardoino describes as “the ultimate pillar of its long-term vision and strategy.
Tether, the stablecoin titan behind USDT, recently announced that it is strategically investing in Blackrock Neurotech, a prominent rival of Elon Musk's neural implant firm Neuralink, to boost brain-computer interface (BCI) technology. In an official statement released by the stablecoin firm today, April 29, significant attention was drawn to the staggering $200 million investment done
Crypto company Tether has invested $200 million in Blackrock Neurotech, taking a majority stake in the U.S. brain implant company, Tether said in a statement on Monday.
TL;DR Tether acquires $200 million majority stake in Blackrock Neurotech. The investment will boost the commercialization of medical devices based on brain signals. Paolo Ardoino, CEO of the company, highlights the transformative potential of Blackrock Neurotech's brain-computer interfaces.
Circle's USDC coin has begun to exceed Tether in terms of stablecoin transaction volume. That's according to Visa's new stablecoin transaction metric, created with Allium Labs to “remove potential distortions that can arise from inorganic activity and other artificial inflationary practices,” as the company said on its website.
Over the years, Tether's USDT has dominated the industry as the preferred stablecoin among its pairs, trading as the third largest crypto after Bitcoin and Ethereum, with a market capitalization of $110.64 billion.
Tether has funneled $200 million into BlackRock Neurotech, securing its position as the majority stakeholder.
Transaction volume in the past 30 days for Tether, USDC, and DAI, has surpassed Visa's 2023 monthly average, according to Nansen.
Stablecoin issuer Tether has invested $200 million in Blackrock Neurotech through its venture division, Tether Evo.
Tether, a leading issuer of stablecoins known for its USDT currency, has made a significant move in the biotechnology sector with a $200 million investment in Blackrock Neurotech.
Tether becomes the majority stakeholder in Blackrock Neurotech with a $200M investment, advancing BCI technology for neurological conditions. The post Tether invests $200 million in Blackrock Neurotech, a top rival of Elon Musk's Neuralink appeared first on Crypto Briefing.
Despite Circle's rising transaction count, Tether's USDT still accounts for over 68% of the entire stablecoin market.
The investment will fund the roll-out and commercialization of the company's medical devices.
Stablecoin issuer Tether has invested $200 million in Blackrock Neurotech, a biotech company, through Tether Evo.
Tether's brand new venture capital division Tether Evo has completed a $200 million strategic investment in the neural implant firm.
Circle Internet Financial's stablecoin, USDC, has achieved a significant milestone in the stablecoin market. It has surpassed Tether's USDT in transaction volume, as pointed out by Visa, a globally recognized digital payments tech company.
